ANTI-INFECTIVE ENDOTRACHEAL TUBE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Anti-Infective Endotracheal Tube Market, By Product Type (Coated Endotracheal Tubes, Silver-Coated Endotracheal Tubes, Antibiotic-Coated Endotracheal Tubes, Uncoated Endotracheal Tubes), By Material (Polyvinyl Chloride (PVC), Silicone, Polyurethane, Others (Rubber, Nylon, etc.)), By End User (Hospitals, Intensive Care Units (ICUs), Emergency Departments, Ambulatory Surgical Centers, Other Healthcare Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Aug 2024
Code : CMI7326
Pages :172
Formats :
Excel and PDF
Industry : Medical Devices

Market Concentration and Competitive Landscape

Anti-Infective Endotracheal Tube Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing number of intensive care unit admissions

Rise in population vulnerability to health deteriorations, availability of improved critical care facilities and aging populations contribute to increasing ICU admissions in hospitals worldwide. ICUs commonly treat patients suffering major trauma injuries, undergoing complex surgeries or battling life-threatening illnesses. Vast majority of patients in ICUs require ventilation support due to respiratory failure, which involves endotracheal intubation. As per some estimates, over 4 million patients are admitted to ICUs annually in the United States. With improving access to healthcare services in developing nations, the global ICU caseload has seen consistent expansion over the past decade.

Prolonged ventilation further increases the threat of hospital-acquired lung infections like ventilator-associated pneumonia. It is one of the most prevalent healthcare-associated infections accounting for over 25% of total HAI burden. Around 10% of all hospitalized patients get into the ICU at some point, thus, it is important to reduce infection rates. Hence, hospitals are increasingly employing anti-infective endotracheal tubes as these significantly reduce VAP occurrence and help ICUs adhere to stringent patient safety and hygiene guidelines.

Key Players Insights